38
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Cytokine Gene Expression after Allogeneic Bone Marrow Transplantation

, , , &
Pages 413-418 | Received 29 Apr 1994, Published online: 01 Jul 2009

References

  • Storb R., Thomas E.D. Graft-versus-Host disease in dog and man: The Seattle experience. Immunological Review 1985; 88: 215–238
  • Ferrara J.L.M., Deeg H.J. Graft versus host disease. N. Engl. J. Med 1991; 324: 667–674
  • Antin J.H., Ferrara J.L.M. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80: 2964–2968
  • Jadus M.R., Wepsic H.T. The role of cytokines in graft-versus-host reactions and disease. Bone Marrow Transplant. 1992; 10: 1–14
  • O'Garra A. Interleukins and the immune system. 1. Lancet 1989; 1: 943–946
  • O'Garra A. Interleukins and the immune system. 2. Lancet 1989; 1: 1003–1005
  • Spits H., Yssel H., Paliard X., Kastelein R., Figdor C., de Vries J.E. IL-4 inhibits IL-2 mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. J. Immunol. 1989; 141: 29–36
  • Martinez O.M., Krams S.M., Sterneck M., Villanueva J.C., Falcon D.A., Ferrell L.D., Lake J., Roberts J.P., Ascher N.L. Intragraft cytokine profile during human liver allograft rejection. Transplantation 1992; 53: 449–456
  • Faull R.J., Russ G.R. Tubular expression of intercellular adhesion molecule-1 during renal allograft rejection. Transplantation 1989; 48: 226–230
  • Maguire J.E., Gresser I., Williams A.H., Kielpinski G.L., Colvin R.B. Modulation of expression of MHC antigens in the kidneys of mice by murine interferon-alpha/beta. Transplantation 1990; 49: 130–134
  • Tilg H., Vogel W., Aulitzky W.E., Herald M., Koenigsrainer A., Margreiter R., Huber C. Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation. Transplantation 1990; 49: 1074–1080
  • Simpson M.A., Madras P.N., Cornaby A.J., Etienne T., Dempsey R.A., Clowes G.H.A., Monaco A.P. Sequential determinations of urinary cytology and plasma and urinary lymphokines in the management of renal allograft recipients. Transplantation 1989; 47: 218–223
  • Van Oers M.H.J., Van der Heyden A. A. A. M.P., Aarden L.A. Interleukin 6 (IL-6) in serum and urine of renal transplant recipients. Clin. Exp. Immunol. 1988; 71: 314–319
  • Holler E., Kolb H.J., Moeller A., Kempeni J., Liesenfeld S., Pechumer H., Lehmacher W., Ruckdeschel G., Gleixner B., Riedner C., Ledderose G., Brehm G., Mittermueller J., Wilmanns W. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990; 75: 1011–1016
  • Symington F.W., Pepe M.S., Chen A.B., Deliganis A. Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans. Transplantation 1990; 50: 518–521
  • Chasty R.C., Lamb W.R., Gallati H., Roberts T.E., Brenchley P.E.C., Liu Yin J.A. Serum cytokine levels in patients undergoing bone marrow transplantation. Bone Marrow Transplant. 1993; 12: 331–336
  • Rowbottom A.W., Riches P.G., Downie C., Hobbs J.R. Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation. Bone Marrow Transplant. 1993; 12: 635–641
  • Imamura M., Hashino S., Kobayashi H., Kobayashi S., Hirano S., Minagawa T., Tanaka J., Fujii Y., Kobayashi M., Kasai M., Sakurada K., Miyazaki T. Serum cytokine levels in bone marrow transplants: Synergistic interaction of interleukin-6, interferon-γ, and tumor necrosis factor-a in graft-versus-host disease. Bone Marrow Transplant., (in press)
  • McCarthy P.L., Abhyankar S., Neben S., Newman G., Sieff C., Thompson R.C., Burakoff S.J., Ferrara J.L.M. Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease. Blood 1991; 78: 1915–1918
  • Allen R.D., Staley T.A., Sidman C.L. Differential cytokine expression in acute and chronic murine graft-versus-host-disease. Eur. J. Immunol. 1993; 23: 333–337
  • Garlisi C.G., Pennline K.J., Smith S.R., Siegel M.I., Umland S.P. Cytokine gene expression in mice undergoing chronic graft-versus-host disease. Molecular Immunol. 1993; 30: 669–667
  • Abhyankar S., Gilliland D.G., Ferrara J.L.M. Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens. Transplantation 1993; 56: 1518–1523
  • Fowler D.H., Kurasawa K., Husebekk A., Cohen P.A., Gress R.E. Cells of Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. J. Immunol. 1994; 152: 1004–1013
  • Parkman R., Lenarsaky C., Barrantes B., Santos R., Weinberg K. Cytokines versus cytotoxic T lymphocytes (CTL) in the pathogenesis of acute graft-versus-host disease (GVHD). J. Cell Biochem. 1992; 16a(suppl)186
  • Dallman M.J., Larsen C.P., Morris P.J. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J. Exp. Med 1991; 174: 493–496
  • Tanaka J., Imamura M., Kasai M., Masauzi N., Watanabe M., Matsuura A., Morii K., Kiyama Y., Naohara T., Higa T., Honke K., Gasa S., Sakurada K., Miyazaki T. Rapid analysis of tumor necrosis factor-alpha mRNA expression during veno-occlusive disease of the liver after allogeneic bone marrow transplantation. Transplantation 1993; 55: 430–432
  • Tanaka J., Imamura M., Kasai M., Masauzi N., Matsuura A., Ohizumi H., Morii K., Kiyama Y., Naohara T., Higa T., Sakurada K., Miyazaki T. Cytokine gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation. Br. J. Haematol 1993; 85: 558–565
  • Granelli-Piperno A. Lymphokine gene expression in vivo is inhibited by cyclosporin A. J. Exp. Med. 1990; 171: 533–544
  • Klimpel G.R., Annable C.R., Cleveland M.G., Jerrells T.R., Patterson J.C. Immunosuppression and lymphoid hypoplasia associated with chronic graft versus host disease is dependent upon IFN-γ production. J. Immunol. 1990; 144: 84–93
  • Lagoo A.S., Lagoo-Deenadayalan S., Lorenz H.M., Byrne J., Barber W.H., Hardy K.J. IL-2, IL-4, and IFN-γ gene expression versus secretion in superantigen-activated T cells. J. Immunol 1994; 152: 1641–1652
  • Rubin L.A., Kurman C.C., Fritz M.E., Biddison W.E., Boutin B., Yarchoan R., Nelson D.L. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J. Immunol. 1985; 135: 3172–3177
  • Siegert W., Josimovic-Alasevic O., Schwerdtfeger R., Baurmann H., Schmidt C.A., Musch R., Schmid H.J., Hartmann R., Henze G., Huhn D., Diamantstein T. Soluble interleukin 2 receptors in patients after bone marrow transplantation. Bone Marrow Transplant. 1990; 6: 97–101
  • Herve P., Wijdenes J., Bergerat J.P., Bordigoni P., Milpied N., Cahn J.Y., Clement C., Beliard R., Morel-Fourrier B., Racadot E., Troussard X., Benz-Lemonie E., Gaud C., Legros M., Attal M., Kloft M., Peters A. Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10). Blood 1990; 75: 1017–1023
  • Lukacs N.W., Kunkel S.L., Burdick M.D., Lincoln P.M., Strieter R.M. Interleukin-1 receptor antagonist blocks chemokine production in the mixed lymphocyte reaction. Blood 1993; 82: 3668–3674
  • Granowitz E.V., Porat R., Mier J.W., Orencole S.F., Callahan M.V., Cannon J.G., Lynch E.A., Ye K., Poutsiaka D.D., Vannier E., Shapiro L., Pribble J.P., Stiles D.M., Catalano M.A., Wolff S.M., Dinarello C.A. Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans. Blood 1993; 82: 2985–2990
  • Degiannis D., Luke-Gustites D., Mikhail N., Raska K, Jr., Raskova J. Binding of phycoerythrin-conjugated inter-leukin-6 to in vitro-activated human peripheral blood mononuclear cells-effect of immunosuppressive agents and of a calcium channel blocker. Transplantation 1992; 54: 308–312
  • Baxter-Lowe L.A., Eckels D.D., Ash R., Casper J., Hunter J.B., Gorski J. The predictive value of HLA-DR oligo-typing for MLC response. Transplantation 1992; 53: 1352–1357
  • DeGast G.C., Mickelson E.M., Beatty P.G., Amos D., Sullivan K.M., Schoch H.G., Thomas E.D., Hansen J.A. Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia. Bone Marrow Transplant. 1992; 9: 87–90
  • Theobald M., Nierle T., Bunles D., Arnold R., Heimpel H. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. N. Engl. J. Med. 1992; 327: 1613–1617
  • Tanaka J., Imamura M., Kasai M., Kobayashi S., Hashino S., Kobayashi H., Sakurada K., Miyazaki T. Cytokine gene expression in the mixed lymphocyte culture in allogeneic bone marrow transplants as a predictive method for transplantation-related complications. Br. J. Haematol, (in press)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.